USPTO serial 79123685
COLIBRA
Reviewed by CopyMark Law Group
Reg. 4409192Status 709
- Filing date
- Status date
- Registration date
- Oct 1, 2013
- Examiner
- SEVERSON, KAREN
- Law office
- —
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with COLIBRA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jamie L Dupree
Jamie L Dupree FUTTERMAN DUPREE DODD CROLEY MAIER LLP601 Montgomery StreetSuite 1210SAN FRANCISCO, CA 94111Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | [ Diagnostic and therapeutic synthetic peptides, proteins, molecules, antibodies, polypeptides and polymers for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitounrinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; diagnostic preparations for medical use, namely, synthetic peptides, proteins, molecules, antibodies, polypeptides and polymers for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, opthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; biochemical and biological substances for medical diagnosis and analytics, namely, pharmaceutical preparations and substances for the diagnosis and analytics of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders ] | SECTION 71 - CANCELLED | — |
| 042 | Scientific, biological, biochemical, and biotechnology research in the field of in-vitro screening and protein engineering; biochemical research services; biotechnological engineering, namely, the engineering of peptides, proteins, molecules, antibodies, polypeptides and polymers | SECTION 71 - CANCELLED | — |
| 045 | Licensing of intellectual property; licensing of technology in the field of in-vitro screening and protein engineering relating to discovery of peptides for therapeutic and non-therapeutic applications | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Isogenica Ltd
- Other trademarks owned by Isogenica Ltd
- Other trademarks owned by Isogenica Ltd
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 045
- Similar marks named COLIBRA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 14, 2025 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Jan 17, 2025 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Jan 17, 2025 | INPC | INVALIDATION PROCESSED | — |
| Dec 13, 2024 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Apr 12, 2024 | C71T | CANCELLED SECTION 71 | — |
| Jul 18, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 18, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 18, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 11, 2022 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Oct 1, 2022 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Aug 13, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 20, 2021 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Feb 4, 2021 | INPS | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Feb 4, 2021 | INPC | INVALIDATION PROCESSED | — |
| Feb 3, 2021 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jun 3, 2020 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Jun 3, 2020 | 71.P | REGISTERED - PARTIAL SEC 71 ACCEPTED | — |
| Jun 2, 2020 | EROP | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | — |
| Jun 2, 2020 | PR71 | POST REGISTRATION ACTION MAILED - SEC.71 | — |
| Jun 1, 2020 | EROP | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | — |
| Nov 6, 2019 | PR71 | POST REGISTRATION ACTION MAILED - SEC.71 | — |
| Nov 1, 2019 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Sep 27, 2019 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Oct 1, 2018 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Sep 19, 2017 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 13, 2015 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 18, 2014 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 28, 2014 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 28, 2014 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 1, 2014 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 1, 2013 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 22, 2013 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jul 16, 2013 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 16, 2013 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 26, 2013 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 26, 2013 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jun 26, 2013 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 7, 2013 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jun 6, 2013 | ALIE | ASSIGNED TO LIE | — |
| Jun 5, 2013 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 5, 2013 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 5, 2013 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 5, 2013 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 5, 2013 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 15, 2013 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 15, 2013 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 14, 2013 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Apr 17, 2013 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Apr 17, 2013 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 17, 2013 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 27, 2013 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 27, 2013 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 27, 2013 | ALIE | ASSIGNED TO LIE | — |
| Mar 26, 2013 | ALIE | ASSIGNED TO LIE | — |
| Mar 25, 2013 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 22, 2013 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 22, 2013 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 19, 2013 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 27, 2013 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 27, 2013 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 27, 2013 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 26, 2013 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 26, 2013 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 29, 2013 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 24, 2013 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 17, 2013 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |